BACE1 and Alzheimer disease: Studies on the amyloid cascade hypothesis have stimulated the development of several potential treatment strategies for AD, such as immunotherapy with the aim of clearing Aβ plaques from the brain, and β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for targeting the BACE enzymes responsible for Aβ production [15].